Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Short-term Investments (2024 - 2025)

Zenas BioPharma has reported Short-term Investments over the past 2 years, most recently at $232.6 million for Q4 2025.

  • Quarterly results put Short-term Investments at $232.6 million for Q4 2025, up 258290.0% from a year ago — trailing twelve months through Dec 2025 was $232.6 million (up 258290.0% YoY), and the annual figure for FY2025 was $232.6 million, up 258290.0%.
  • Short-term Investments for Q4 2025 was $232.6 million at Zenas BioPharma, up from $175.3 million in the prior quarter.
  • Over the last five years, Short-term Investments for ZBIO hit a ceiling of $232.6 million in Q4 2025 and a floor of $86000.0 in Q1 2024.